Preliminary Findings from the Swedish Myasthenia Gravis Registry
Wanqing Wu, a PhD student from Karolinska Institute, discusses the Swedish Myasthenia Gravis (MG) Registry at the EAN 2024. Initiated in 2011, the registry includes over 1,700 MG patients, representing about 60% of Sweden’s MG population. Preliminary findings include the average age of MG onset at 50 years, common antibody presence, and significant use of rituximab.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in